Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 260 clinical trials
Intensified Tuberculosis Treatment to Reduce the Mortality of Patients With Tuberculous Meningitis

INTENSE-TBM is randomized controlled, phase III, multicenter, 2 x 2 factorial plan superiority trial assessing the efficacity of two interventions to reduce mortality from tuberculous meningitis

  • 0 views
  • 24 Feb, 2021
  • 12 locations
Optimizing Antituberculosis Therapy in Adults With Tuberculous Meningitis

previous studies. The investigators hypothesize that among rapid acetylators high dose isoniazid would result in lower rates of death and disability in patients with tuberculous meningitis than the rates

  • 0 views
  • 05 Feb, 2021
  • 4 locations
Efficacy of Nyaditum Resae(R) Against Active TB in Georgia

The use of a supplement food like "Nyaditum resae" is a reliable opportunity to stop the progression towards active TB through the most updated knowledge of this disease:the induction of

  • 23 views
  • 21 Jan, 2021
  • 1 location
Xpert MTB/RIF Test in the Diagnosis of Pulmonary Tuberculosis

Currently in Taiwan, most clinicians use sputum smear and culture for the diagnosis of pulmonary tuberculosis (TB) and apply nucleic acid amplification (NAA) test in a selected manner. In 2013

  • 0 views
  • 26 Jan, 2021
  • 5 locations
Pharmacokinetic Study to Evaluate Anti-mycobacterial Activity of TMC207 in Combination With Background Regimen (BR) of Multidrug Resistant Tuberculosis (MDR-TB) Medications for Treatment of Children/Adolescents Pulmonary MDR-TB

and adolescents (0 months to less than [<] 18 years of age) diagnosed with confirmed or probable pulmonary multidrug resistant tuberculosis (MDR-TB), in combination With a Background Regimen (BR

chest x-ray
extensively drug-resistant tuberculosis
tmc207
bedaquiline
pulmonary tuberculosis
  • 94 views
  • 25 Feb, 2021
  • 9 locations
Multicenter Trial for the Evaluation of a Fixed Dose Combined Tablet for the Treatment of Pulmonary Tuberculosis

The use of fixed-dose combined (FDC) drugs in the treatment of tuberculosis by National Tuberculosis Programmes has been recommended by both the International Union Against Tuberculosis

hiv test
isoniazid
tb chemotherapy
rifampin
smear
  • 42 views
  • 07 Nov, 2020
  • 7 locations
A Controlled Trial of a 4-Month Quinolone-Containing Regimen for the Treatment of Pulmonary Tuberculosis

Tuberculosis is currently treated with a 6-month course regimen. During this time many patients might fail to adhere to treatment and default, increasing the risk of recurrent disease

pulmonary tuberculosis
  • 85 views
  • 07 Nov, 2020
  • 5 locations
Two-month Regimens Using Novel Combinations to Augment Treatment Effectiveness for Drug-sensitive Tuberculosis

The current standard management strategy for drug-sensitive pulmonary tuberculosis (TB) is to treat with multiple drugs for 6 months, although patients often fail to adhere to the long treatment

rifapentine
levofloxacin
linezolid
bedaquiline
clofazimine
  • 192 views
  • 22 Jan, 2021
  • 14 locations
Study to Evaluate H56:IC31 in Preventing Rate of TB Recurrence

-negative adults with a diagnosis of drug susceptible pulmonary TB are planned to be included, recruited from TB clinics with established relationships to the trial sites at the start of their TB treatment

smear
  • 0 views
  • 27 Jan, 2021
  • 6 locations
  • 0 views
  • 04 Mar, 2021
  • 16 locations